Virax Biolabs (VRAX) Non-Current Debt (2022 - 2023)
Virax Biolabs (VRAX) reported Non-Current Debt of -$18,296 for FY2024 (year ended Mar 31, 2024), compared with -$111,645 in FY2023.
Powered by 
Analysis
Virax Biolabs (VRAX) Non-Current Debt (2022 - 2023) Analysis & Trends
- According to Business Quant data, Non-Current Debt came in at -$111,645 in FY2023 and $193,592 in FY2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 257.88 Bn | 236.91 Bn | 4.88 Bn | 39.18 Bn |
| 2 | Abbott Laboratories | 173.37 Bn | 143.80 Bn | 7.27 Bn | 29.60 Bn |
| 3 | Danaher | 162.26 Bn | 146.07 Bn | 3.61 Bn | 25.15 Bn |
| 4 | Intuitive Surgical | 149.66 Bn | 129.09 Bn | 1.96 Bn | - |
| 5 | Medtronic | 120.13 Bn | 85.39 Bn | 6.34 Bn | 25.62 Bn |
| 6 | Stryker | 113.84 Bn | 99.96 Bn | 4.50 Bn | 14.19 Bn |
| 7 | Boston Scientific | 65.43 Bn | 60.20 Bn | 3.85 Bn | 10.92 Bn |
| 8 | Becton Dickinson | 53.41 Bn | 50.56 Bn | 2.32 Bn | 13.51 Bn |
| 9 | Edwards Lifesciences | 50.58 Bn | 34.59 Bn | 1.35 Bn | 598.70 Mn |
| 10 | Virax Biolabs | 572,529.62 | -20.73 Mn | - | - |
API Access
Virax Biolabs Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=VRAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "VRAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=VRAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();